Clinic
Ponca City Immediate Care, LLC
Ponca City Immediate Care, LLC was paid $3.77M by Medicaid between Dec 2019 and Aug 2024, across 31 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 54% of everything it billed.
33Billing provider infoPONCA CITY IMMEDIATE CARE, LLC
PONCA CITY, OK 74601
PONCA CITY, OK 74601
33aNPI1740837889assigned 08/22/2019
33bProvider typeUrgent Care Clinic/Center
28Total paid$3.77M
24GClaims62,930
24DCodes billed31
24AFirst – last monthDec 2019 – Aug 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Oklahoma
Rank by total paid#9 of 71
Median peer was paid$441K
This provider vs. median8.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 2,180 | $99K | |
| 2020 | 9,822 | $577K | |
| 2021 | 15,480 | $893K | |
| 2022 | 15,652 | $999K | |
| 2023 | 13,254 | $805K | |
| 2024incomplete | 6,542 | $400K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 54% | 19,181 | 18,222 | $2.03M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 12% | 6,543 | 6,388 | $467K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 9.2% | 8,586 | 8,466 | $348K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 6.9% | 1,784 | 1,783 | $260K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 6.2% | 8,134 | 8,029 | $233K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3.4% | 1,514 | 1,502 | $128K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.2% | 5,731 | 5,671 | $84K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.0% | 778 | 778 | $74K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.3% | 512 | 507 | $51K |
| 87081 | <1% | 4,117 | 4,076 | $24K | |
| 87634 | <1% | 244 | 244 | $15K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 656 | 648 | $14K |
19 more codes
| 99051 | <1% | 1,702 | $11K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,477 | $10K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 635 | $8K |
| 87807 | <1% | 563 | $7K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 98 | $3K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 33 | $2K |
| 86756 | <1% | 130 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 99 | $855.36 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 36 | $418.32 |
| 36415 | Collection of venous blood by venipuncture | <1% | 102 | $374.33 |
| 86308 | <1% | 43 | $198.23 | |
| 82565 | <1% | 38 | $163.80 | |
| 80051 | <1% | 25 | $156.00 | |
| 82550 | <1% | 25 | $144.75 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 13 | $109.72 |
| 84520 | <1% | 26 | $91.26 | |
| 82947 | <1% | 25 | $87.50 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 55 | $53.02 |
| 81003 | <1% | 25 | $50.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROSS, CHADWICK (MEDICAL DIRECTOR)